Overall, an evaluation of results from such in vivo studies elucidates that the chemoprotective and antitumor roles of phytoestrogens in breast cancer are influenced by several factors, including the timing of phytoestrogen exposure, ERα vs. ERβ expression status of the tissue, and the local hormonal environment. This evidence concerns the gene ESR1 and breast cancer.